Kristina Aghababyan

Dr. Kristina Aghababyan

Hospital General Universitario de Valencia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MCMaría Castaño
María Castaño
SPSarai Tomás Pérez
Sarai Tomás Pérez
EGEva González-Cantó
Eva González-Cantó
KAKristina Aghababyan
Kristina Aghababyan
AMAndrea Mascarós-Martínez
Andrea Mascarós-Martínez
Juan Gilabert-EstellésJuan Gilabert-Estellés
Juan Gilabert-Estellés
Neutrophils, the most abundant circulating leukocytes, play a well-known role in defense against pathogens through phagocytosis and degranulation. However, a new mechanism involving the release of neutrophil extracellular traps (NETs) composed of DNA, histones, calprotectin, myeloperoxidase, and elastase, among others, has been described. The so-called NETosis process can occur through three different mechanisms: suicidal, vital, and mitochondrial NETosis. Apart from their role in immune defense, neutrophils and NETs have been involved in physiopathological conditions, highlighting immunothrombosis and cancer. Notably, neutrophils can either promote or inhibit tumor growth in the tumor microenvironment depending on cytokine signaling and epigenetic modifications. Several neutrophils’ pro-tumor strategies involving NETs have been documented, including pre-metastatic niche formation, increased survival, inhibition of the immune response, and resistance to oncologic therapies. In this review, we focus on ovarian cancer (OC), which remains the second most incidental but the most lethal gynecologic malignancy, partly due to the presence of metastasis, often omental, at diagnosis and the resistance to treatment. We deepen the state-of-the-art on the participation of NETs in OC metastasis establishment and progression and their involvement in resistance to chemo-, immuno-, and radiotherapies. Finally, we review the current literature on NETs in OC as diagnostic and/or prognostic markers, and their contribution to disease progression at early and advanced stages. The panoramic view provided in this article might pave the way for enhanced diagnostic and therapeutic strategies to improve the prognosis of cancer patients and, specifically, OC patients.

Verified
Journal Article
Open access
PDF file
Josep Marí AlexandreJosep Marí Alexandre
Josep Marí Alexandre
ACAntonio Pellín Carcelén
Antonio Pellín Carcelén
KAKristina Aghababyan
Kristina Aghababyan
AMAndrea Moreno-Manuel
Andrea Moreno-Manuel
JGJavier García-Oms
Javier García-Oms
Juan Gilabert-EstellésJuan Gilabert-Estellés
Juan Gilabert-Estellés
Ovarian cancer and endometriosis are two distinct gynaecological conditions that share many biological aspects incuding proliferation, invasion of surrounding tissue, inflammation, inhibition of apoptosis, deregulation of angiogenesis and the ability to spread at a distance. miRNAs are small non-coding RNAs (19–22 nt) that act as post-transcriptional modulators of gene expression and are involved in several of the aforementioned processes. In addition, a growing body of evidence supports the contribution of oxidative stress (OS) to these gynaecological diseases: increased peritoneal OS due to the decomposition of retrograde menstruation blood facilitates both endometriotic lesion development and fallopian tube malignant transformation leading to high-grade serous ovarian cancer (HGSOC). Furthermore, as HGSOC develops, increased OS levels are associated with chemoresistance. Finally, continued bleeding within ovarian endometrioma raises OS levels and contributes to the development of endometriosis-associated ovarian cancer (EAOC). Therefore, this review aims to address the need for a better understanding of the dialogue between miRNAs and oxidative stress in the pathophysiology of ovarian conditions: endometriosis, EAOC and HGSOC.

Verified
Journal Article
Open access
PDF file
BCBarbara Mc Cormack
Barbara Mc Cormack
EGEva González-Cantó
Eva González-Cantó
KAKristina Aghababyan
Kristina Aghababyan
NENancy A. Espinoza-Sánchez
Nancy A. Espinoza-Sánchez
SPSarai Tomás Pérez
Sarai Tomás Pérez
Juan Gilabert-EstellésJuan Gilabert-Estellés
Juan Gilabert-Estellés
In recent years, interest in personalized medicine has considerably increased

18 November 2024 in Cells
Verified
Journal Article
Open access
PDF file
EGEva González-Cantó
Eva González-Cantó
MMMariana Monteiro
Mariana Monteiro
KAKristina Aghababyan
Kristina Aghababyan
AFAna Ferrero-Micó
Ana Ferrero-Micó
SNSergio Navarro-Serna
Sergio Navarro-Serna
Josep Marí AlexandreJosep Marí Alexandre
Josep Marí Alexandre
High-grade serous ovarian cancer (HGSOC) is the most lethal form of gynecologic cancer, with limited treatment options and a poor prognosis. Epigenetic factors, such as microRNAs (miRNAs) and DNA methylation, play pivotal roles in cancer progression, yet their specific contributions to HGSOC remain insufficiently understood. In this study, we performed comprehensive high-throughput analyses to identify dysregulated miRNAs in HGSOC and investigate their epigenetic regulation. Analysis of tissue samples from advanced-stage HGSOC patients revealed 20 differentially expressed miRNAs, 11 of which were corroborated via RT-qPCR in patient samples and cancer cell lines. Among these, miR-145-3p was consistently downregulated post-neoadjuvant therapy and was able to distinguish tumoural from control tissues. Further investigation confirmed that DNA methylation controls MIR145 expression. Functional assays showed that overexpression of miR-145-3p significantly reduced cell migration and induced G0/G1 cell cycle arrest by modulating the cyclin D1-CDK4/6 pathway. These findings suggest that miR-145-3p downregulation enhances cell proliferation and motility in HGSOC, implicating its restoration as a potential therapeutic target focused on G1/S phase regulation in the treatment of HGSOC.

Verified
Journal Article
Open access
PDF file
BCBarbara Mc Cormack
Barbara Mc Cormack
EGEva González-Cantó
Eva González-Cantó
SPSarai Tomás Pérez
Sarai Tomás Pérez
KAKristina Aghababyan
Kristina Aghababyan
Josep Marí AlexandreJosep Marí Alexandre
Josep Marí Alexandre
Juan Gilabert-EstellésJuan Gilabert-Estellés
Juan Gilabert-Estellés
Personalized medicine has become a new paradigm in the management of a variety of diseases

10 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
VLValentina Lorenzi
Valentina Lorenzi
MMMarie Moullet
Marie Moullet
CICecilia Icoresi-Mazzeo
Cecilia Icoresi-Mazzeo
RCRyan Colligan
Ryan Colligan
MDMolly R. Danks
Molly R. Danks
RVRoser Vento-Tormo
Roser Vento-Tormo
The human endometrium (uterine lining) undergoes cyclical breakdown and scarless regeneration during each menstrual cycle, representing an exceptional model of adult tissue renewal. Regeneration is driven primarily by progenitor cells retained within the deep, basalis compartment during menstruation, yet the full-depth spatiotemporal dynamics of this process have remained understudied due to anatomical and technical limitations. Here, we map spatial gene-expression gradients across the full thickness of the human endometrium, from the myometrial-endometrial boundary to the luminal surface, using high-resolution spatial transcriptomics integrated with single-cell transcriptomics. We profile more than ten million cells from biopsies, hysterectomy samples and menstrual fluid, enriching for the menstrual and proliferative phases, which are underrepresented in previous studies. We show that endometrial breakdown, regeneration and rapid luminal re-epithelialisation are concurrent rather than temporally separated, organised across distinct tissue compartments, revealing a mode of tissue renewal in which shedding and repair operate simultaneously. Continuous basalis-to-luminal transcriptional gradients link progenitor identity, niche signalling, and tissue remodelling, defining a coordinated regenerative axis spanning the full tissue depth. We resolve the basalis epithelial niche at unprecedented molecular resolution, identifying for the first time a discrete, predominantly quiescent progenitor-like epithelial subset and specialised supporting SFRP5 + fibroblasts, both characterised by WNT inhibition, alongside lymphoid aggregates, forming a multi-component architecture that persists after menopause, consistent with a long-lived regenerative reservoir. Together, these findings establish spatial transcriptional gradients as a central organising principle of endometrial renewal, providing a molecular framework for understanding disorders of menstruation, implantation failure, and impaired tissue repair.